Access cutting-edge glioma of brain treatment through this phase 2 clinical trial at a research site in Omaha. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Omaha location
Preparing your pre-screening questions…
Access glioma of brain specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related glioma of brain treatment provided free
Check if you qualify for this glioma of brain clinical trial in Omaha, NE
No-Cost Study Care
Local to Omaha
Convenient for NE residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Glioma is a cancer of glial cells, a class of tissue supporting neuronal function in the brain. As many as 85% of glioma patients experience cognitive impairment. This is not only from direct tumor involvement, but also from therapy such as cranial radiation and chemotherapy, which degrades neuronal function. There is evidence that serotonin selective reuptake inhibitors (SSRIs), such as escitalopram, improve cognition or prevent cognitive decline and may also improve outcomes critical to overall survival including functional independence, psychosocial stability, and quality of life. This pilot study will evaluate the effectiveness of the selective serotonin reuptake inhibitor (SSRI) escitalopram for treating cognitive impairment in newly diagnosed grade IV glioma over a 17 week treatment period.
Sponsor: University of Nebraska
Yes, this clinical trial (NCT03728673) has an active research site in Omaha, NE that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for glioma of brain treatment options in Omaha, NE, this clinical trial (NCT03728673) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Omaha research site is actively enrolling participants for this phase 2 clinical trial. You'll receive care from experienced glioma of brain specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all glioma of brain clinical trials near you to find additional studies recruiting in your area.
See all brain cancer clinical trials recruiting in Omaha — not just this study.
Browse Brain Cancer Trials in Omaha →